Latest news
Oculis to Acquire Full Rights to Privosegtor in Asset Deal with Accure Therapeutics - tipranks.comtipranks.com · Mon, 10 Aug 2026 13:04:03 GMTOculis signs asset deal with Accure Therapeutics for privosegtor - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 12:33:45 GMTAlmirall strengthens China footprint with CrystalO collaboration - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 12:33:45 GMTOculis Holding (OCS) inks $3.8M cash-plus-shares deal for Privosegtor rights - Stock TitanStock Titan · Mon, 10 Aug 2026 12:00:34 GMTAstronauTx exercises option on Saniona-partnered Alzheimer's candidate - The Pharma LetterThe Pharma Letter · Mon, 10 Aug 2026 11:41:40 GMTOculis to Buy Accure's Global Development, Commercial Rights to Privosegtor - Yahoo FinanceYahoo Finance · Mon, 10 Aug 2026 08:45:17 GMTPreliminary data on early redemptions (prepayments) - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 07:56:36 GMTZelluna ASA: New share capital registered - The Manila TimesThe Manila Times · Mon, 10 Aug 2026 07:56:35 GMT